Aurobindo Pharma Limited (NSE:AUROPHARMA)
1,070.80
-19.30 (-1.77%)
Oct 8, 2025, 3:30 PM IST
Revenue by Product
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Revenue by Geography
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.